#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cerebral arteriovenous malformation haemorrhagic Synovial sarcoma metastatic Vernal keratoconjunctivitis Infantile apnoea Von Hippel-Lindau disease Osteosarcoma metastatic Fatty acid oxidation disorder Acute on chronic liver failure Hereditary spastic paraplegia Non-small cell lung cancer recurrent Squamous cell carcinoma of head and neck Neuronal ceroid lipofuscinosis Neonatal asphyxia Antithrombin III deficiency Follicular lymphoma More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma metastatic – Diagnostics Synovial sarcoma – Trials in Disease Arterial tortuosity syndrome Basal cell naevus syndrome – Basic Information Usher’s syndrome – Trials in Disease Glomerulonephritis membranous – Life with Disease Von Willebrand’s disease – Life with Disease Haemophilia – Diagnostics Small intestine leiomyosarcoma – Diagnostics Pulmonary fibrosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Permethrin BRENSOCATIB Folic Acid Tavapadon TX000045 Ucp2 Carbamazepine (Ph. Eur.) Dacarbazine Triptorelin Protamine Sulfate Sotalol GSKVX000000044501 Bcmacp03 Sepiapterin Secale Cereale Sodium Citrate Depemokimab Levofloxacin Hemihydrate Giroctocogene Fitelparvovec Nilutamide More therapies…

    Learn about Your Condition

    Death neonatal Infection Psychotic behaviour ROHHAD syndrome Fibrous dysplasia of bone Systemic infection Incontinence Ependymoma malignant Cervix carcinoma stage II Haemorrhage intracranial Tooth loss Infectious pleural effusion Anal incontinence Stress cardiomyopathy Procedural anxiety More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Effect of levothyroxine on kidney function in patients at risk of hypothyroidism after partial thyroid surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypothyroidism
    • Chronic kidney disease
    Investigated Drugs:
    • Levothyroxine
    Denmark

  • A study comparing different zinc doses for the treatment of Wilson disease in healthy participants.

    Recruiting

    2 1 1
    Investigated Diseases:
    • Hepato-lenticular degeneration
    Investigated Drugs:
    • Copper (64Cu) Chloride
    • ZINC
    Denmark

  • A study to evaluate the long-term safety and effectiveness of mRNA-3927 in patients with Propionic Acidemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Propionic acidaemia
    Investigated Drugs:
    • Modified Messenger Ribonucleic Acid Encoding Human Propionyl-Coenzyme A Carboxylase Alpha And Beta Subunits Encapsulated Into Lipid Nanoparticles
    France The Netherlands Spain

  • N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD

    Recruiting

    3 1
    Investigated Diseases:
    • Metabolic dysfunction-associated liver disease
    Investigated Drugs:
    • Ly3437943 Sodium
    • Tirzepatide
    Austria Belgium Bulgaria Czechia France Germany +9

  • Phase 3 Evaluation of Etelcalcetide for Secondary Hyperparathyroidism in Pediatric Patients with Chronic Kidney Disease on Hemodialysis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperparathyroidism secondary
    Investigated Drugs:
    • Etelcalcetide
    Belgium Czechia Germany Greece Italy Poland +2

  • A Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease

    Recruiting

    2 1
    Belgium Denmark France Germany Italy The Netherlands +1
Previous Page
1 … 3 4 5 6 7 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!